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Toxicological and anti-tumor effects of a linden
extract (Tilia platyphyllos Scop.) in a
HPV16-transgenic mouse model
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Tilia platyphyllos Scop. is a popular broad-leaved tree, native to Central and Southern Europe.
Hydroethanolic extracts rich in phenolic compounds obtained from T. platyphyllos Scop. have shown
in vitro antioxidant, anti-inflammatory and antitumor properties. The aim of this work was to evaluate the
therapeutic properties of a hydroethanolic extract obtained from T. platyphyllos in HPV16-transgenic
mice. The animals were divided into eight groups according to their sex and phenotype. Four groups of
female: HPV+ exposed to linden (HPV linden; n = 6), HPV+ (HPV water; n = 4), HPV− exposed to linden
(WT linden; n = 5) and HPV− (WT water; n = 4) and four groups of male: HPV+ exposed to linden (HPV
linden; n = 5), HPV+ (HPV water; n = 5), HPV− exposed to linden (WT linden; n = 5) and HPV− (WT water;
n = 7). The linden (Tilia platyphyllos Scop.) extract was orally administered at a dose of 4.5 mg/10 mL per
animal (dissolved in water) and changed daily for 33 days. The hydroethanolic extract of T. platyphyllos
consisted of protocatechuic acid and (−)-epicatechin as the most abundant phenolic acid and flavonoid,
respectively, and was found to be stable during the studied period. In two male groups a significant posi-
tive weight gain was observed but without association with the linden extract. Histological, biochemical,
and oxidative stress analyses for the evaluation of kidney and liver damage support the hypothesis that the
linden extract is safe and well-tolerated under the present experimental conditions. Skin histopathology
does not demonstrate the chemopreventive effect of the linden extract against HPV16-induced lesions.
The linden extract has revealed a favourable toxicological profile; however, additional studies are required
to determine the chemopreventive potential of the linden extract.
1. Introduction
Tilia platyphyllos Scop., popularly known as linden, is a decid-
uous broad-leaved tree.1,2 Native to Central and Southern
Europe, this plant species belongs to the Malvacaeae family.3
T. platyphyllos Scop. is characterized by fast growth, positive
impact on soil fertility and great resistance to unfavourable
external conditions.4 Linden has important biological pro-
aCentre for the Research and Technology of Agro-Environmental and Biological
Sciences (CITAB), Inov4Agro, University of Trás-os-Montes and Alto Douro (UTAD),
Vila Real, Portugal. E-mail: pamo@utad.pt
bAnimal and Veterinary Research Centre (CECAV), UTAD, Vila Real, Portugal
cMolecular Oncology and Viral Pathology Group, IPO-Porto Research Center
(CI-IPOP), Portuguese Institute of Oncology of Porto (IPO-Porto), Porto, Portugal
dLEPABE—Laboratory for Process Engineering, Environment, Biotechnology and
Energy, Faculty of Engineering, University of Porto, Porto, Portugal
ePostgraduate Programme in Adult Health (PPGSAD), Tumour and DNA Biobank,
Federal University of Maranhão (UFMA), São Luís, Brazil
fCESPU, Institute of Research and Advanced Training in Health Sciences and
Technologies, Gandra, Portugal
gi3s, LAS, IBMC, UP, Porto, Portugal
hDepartment of Genetic and Biotechnology and CECAV, UTAD, Vila Real, Portugal
iFaculty of Veterinary Medicine, Lusophone University of Humanities and
Technologies, Lisbon, Portugal
jFaculty of Medicine, University of Porto (FMUP), Porto, Portugal
kVirology Service, Portuguese Oncology Institute of Porto (IPO Porto), Porto,
Portugal
lCEBIMED, Faculty of Health Sciences, Fernando Pessoa University, Porto, Portugal
mResearch Department of the Portuguese League Against Cancer—Regional Nucleus
of the North (Liga Portuguesa Contra o Cancro—Núcleo Regional do Norte), Porto,
Portugal
nCentro de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança,
Campus de Santa Apolónia, 5300-253 Bragança, Portugal
†Both of them are first authors.






















































View Journal  | View Issue
perties such as diuretic, antispasmodic, sedative, antioxidant,
hepatoprotective and anti-neuralgic properties.5
Protocatechuic acid and (−)-epicatechin are the most abundant
phenolic acid and flavonoid in T. platyphyllos Scop. respect-
ively.3 A hydroethanolic extract rich in phenolic compounds
obtained from T. platyphyllos Scop. has demonstrated anti-
oxidant, anti-inflammatory and antitumor effects in vitro.3
Several animal experiments indicate that protocatechuic acid
may have protective effects against epithelial malignancies in
different tissues6 such as bladder7 and skin cancers.8
Moreover, epicatechin has demonstrated a significant antioxi-
dative activity and has shown cardioprotective, anti-diabetic
and neuroprotective activities.9 Human papillomavirus (HPV)
is an infectious agent responsible for 5% of all human
cancers, and is transmitted by direct contact.10 HPV belongs to
the Papillomaviridae family and is an icosahedral and non-
enveloped virus with circular double-strand DNA. The viral
genome consists of three regions: the early region, the late
region and the long control region.11,12 This virus can be
divided into two groups: high-risk and low-risk types. The
latter causes warts that are eliminated by the immune system
whereas the high-risk HPVs (namely the HPV16 and 18 types),
after persistent infection, are the major cause of anogenital
and oropharyngeal cancers in both sexes.13 The HPV16 early
genomic region encodes the E5, E6 and E7 oncoproteins that
are essential for the development of malignant lesions
whereas the late region encodes the capsid proteins.13,14 For
this reason, our team chose a transgenic mouse model carry-
ing the complete HPV16 early region15 to study the effects of
T. platyphyllos Scop. when administered orally to HPV16-trans-
genic mice. The aims of these experiments were to test the
potential chemopreventive effects of the extract against the
development of HPV16-induced lesions and to determine its
in vivo toxicity in this animal model.
2. Methods
2.1. Sample preparation
The aerial parts of Tilia platyphyllos Scop. were provided by
Cantinho das Aromáticas, organic farmers from Vila Nova de
Gaia (Portugal). The dried samples were ground into powder
and subjected to an extraction procedure at room temperature
(≈25 °C) as follows: 5 g of T. platyphyllos was extracted under
magnetic stirring for 1 h in the dark with 150 mL of ethanol :
water (80 : 20, v/v), filtered and re-extracted under the same
conditions. Then, ethanol was removed using a rotary evapor-
ator (Büchi R-210, Flawil, Switzerland), and water was removed
by lyophilisation. The concentration used to feed the animals
was determined based on the IC50 value obtained in in vitro
anti-inflammatory studies performed by us previously (225 µg
mL−1), and it was decided to administrate 2× the IC50 concen-
tration to guarantee the phenolic compound concentration.3
Therefore, the extract was dissolved in water at a concentration
of 450 μg mL−1 (4.5 mg in 10 mL of water), and the solution
was renewed every day for the in vivo studies.
2.2. Profiles of phenolic compounds and stability of the
aqueous extracts
The phenolic compounds were determined using a Dionex
Ultimate 3000 UPLC (Thermo Scientific, San Jose, CA, USA),
accolated with a diode-array detector (DAD, 280, 330 and
370 nm as preferred wavelengths), and a mass detector
equipped with an ESI source (Linear Ion Trap LTQ XL, Thermo
Finnigan, San Jose, CA, USA) following a previously described
procedure.16 The identification of different phenolic com-
pounds was performed by comparison with the available com-
mercial standards, or tentatively identified using the reported
data from the literature. For quantitative analysis, a calibration
curve for each available phenolic standard was constructed
based on the UV-Vis signal or when no commercial standard
was available a similar compound from the same phenolic
group was used as a standard and the results were expressed
in mg mL−1 of extract. The stability of the drinking water
(5 mg mL−1) was evaluated during 5 consecutive days at room
temperature, and analyzed daily using an LC-DAD-ESI/MS
system to visualize if any possible degradation of the phenolic
compounds has occurred.
2.3. Animals
This study was approved by the University of Trás-os-Montes
and Alto Douro Ethics committee (approval no. 10/2013) and
the Portuguese Veterinary Authorities (approval no. 0421/000/
000/2014). This experimental trial followed the national legis-
lation (Decree-Law 113/2013, August 7) and European Directive
2010/63/EU on the protection of animals for experiments.
Forty-two K14HPV16 mice on an FVB/n background [22 wild-
type (HPV16−) and 20 hemizygotic (HPV16+)] with 8 weeks of
age were selected for this experimental assay. This study was
performed with both female and male mice (12 males and 10
females, wild-type; and 10 males and 10 females, transgenic).
This animal model was generously donated by Dr. Jeffrey
Arbeit and Dr. Douglas Hanahan through the USA National
Cancer Institute Mouse Repository, University of California.
The animals were maintained under controlled conditions of
temperature (23 ± 2 °C) and relative humidity (50 ± 10%), with
a photoperiod cycle of 12 h light and 12 h darkness. All
animals had ad libitum access to standard diet (Mucedola
4RF21 Certificate, Milan, Italy) and water and were housed in
polycarbonate cages with corncob bedding (Ultragene, Santa
Comba Dão, Portugal). Environmental enrichment was placed
in each cage and the cages were cleaned weekly.
2.4. Experimental design
The linden extract was administered orally at a dose of 4.5 mg/
10 mL per animal (dissolved in water) and changed daily. The
animals were divided into eight groups according to their sex
and phenotype. Four groups of female: HPV+ exposed to
linden (HPV linden; n = 6), HPV+ (HPV water; n = 4), HPV−
exposed to linden (WT linden; n = 5) and HPV− (WT water; n =
4) and four groups of male: HPV+ exposed to linden (HPV
linden; n = 5), HPV+ (HPV water; n = 5), HPV− exposed to
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linden (WT linden; n = 5) and HPV− (WT water; n = 7). The
assay lasted 33 days and during this time the animals’ health
was checked daily. Their body weights and food intake were
registered weekly and water consumption was recorded daily.
At the end of the experimental period, all animals were sacri-
ficed by intraperitoneal administration of an overdose of xyla-
zine–ketamine, followed by cardiac puncture and exsanguina-
tion, according to the Federation of European Laboratory
Animal Science Association (FELASA) guidelines.17 During
necropsy, the ear skin and internal organs were collected,
weighed and fixed in 10% neutral formaldehyde for histo-
logical analysis.
2.5. Haematology
The blood samples were centrifuged (12 000 rpm for 5 min) in
capillary tubes for the determination of microhematocrit
values. Also, the blood samples were placed in heparin tubes
and centrifuged at 3000 rpm for 15 min to obtain plasma. The
plasma was frozen at −80 °C until use. Using an autoanalyzer
(Prestige 24i, Cornay PZ) the concentration of alanine amino-
transferase (ALT), aspartate aminotransferase (AST), creatinine
and urea were determined to verify the hepato- and nephro-
toxic effects.
2.6. Histology
Fixed skin, kidney, liver and spleen samples were routinely
processed for light microscopy. The paraffin-embedded
samples were cut into 2 µm sections and stained with hema-
toxylin and eosin for histological examination under a light
microscope. Skin ear lesions were classified as normal skin,
epidermal hyperplasia (mild, moderate or marked), dysplasia
and carcinoma in situ (CIS).18 The kidney, liver and spleen
tissue samples were histologically evaluated for morphological
alterations, including the presence of inflammation or
necrosis.
2.7. Oxidative stress
To determine the liver and kidney oxidative stress parameters,
the frozen samples were processed as previously described.19
For protein determination, the supernatant was collected, and
the protein content was measured at 280 nm using a Take3
Multi-Volume plate (Take3 plate, BioTek Instruments, USA). All
samples were analysed in duplicate using 20 µL of tissue at
30 °C using a PowerWave XS2 microplate scanning spectro-
photometer (BioTek Instruments, USA) or a Varian Cary
Eclipse (Varian, USA) spectrofluorometer. The determinations
were assayed with modifications according to previous
studies.20,21 Reactive oxygen species (ROS) were measured
using the probe 2′,7′-dihlorofluoresceindiacetate (DCFH-DA),
the fluorescence intensity was measured with excitation and
emission at 488 nm and 510 nm, respectively and expressed as
µmol DCF mg protein-1 based on a standard of DCF
(0–1 mM).22 Superoxide dismutase (SOD) activity was
measured through the inhibition of photochemical reduction
of nitroblue tetrazolium in the reaction with the addition of
xanthine-oxidase (530 nm);23 SOD of bovine erythrocytes was
used to obtain a standard curve (0–30 U mL−1) and the results
were expressed as U mg−1 protein. Catalase activity (CAT) was
estimated at 240 nm (ref. 24) being calculated using a bovine
catalase standard curve (0–30 U mL−1) and the results were
expressed in U mg−1 protein. The glutathione S-transferase
(GST) activity was determined by combining 2,4-dinitrochloro-
benzene (CDNB) with reduced glutathione (340 nm)25 and the
results were expressed as nmol CDNB/min mg−1 of protein
using the extinction coefficient for CDNB of 9.6 mM−1 cm−1.
The concentrations of the reduced (GSH) and oxidized (GSSG)
glutathione states were determined based on the derivatization
with ortho-phthalaldehyde. The fluorescence intensity was
measured with excitation and emission at 320 nm and
420 nm, respectively.26 Concentrations were calculated based
on the GSH and GSSG standard curves (0–1 mM). The coeffi-
cient between GSH and GSSG or the oxidative stress index
(OSI) was then calculated. Malondialdehyde (MDA) levels, as
an indicator of lipid peroxidation, were determined by a thio-
barbituric acid (TBA) based method (530 nm and 600 nm non-
specific).27 The MDA was calculated according to a standard
curve (0–500 µM) of malondialdehyde bis(dimethyl acetal) and
the results were expressed as µmol MDA per mg of protein.
2.8. Statistical analysis
The ponderal gain was calculated as previously described.28
Relative organ weights were calculated by the ratio of the
animals’ organ weights to their body weights. The
Kolmogorov–Smirnov test was performed to verify the normal-
ity of the data. Analysis of variance (ANOVA) was used with the
Bonferroni test and the data were expressed as mean ± SE
(standard error). The histological results were analysed using a
Chi-square test. The analyses were performed using IBM SPSS
version 25 (Statistical Package for the Social Sciences, Chicago,
Illinois, USA) and the results were considered statistically sig-
nificant when p < 0.05.
3. Results
3.1. Phenolic composition
The chromatographic compound characteristics (retention
time, λmax in the UV-Vis, and mass spectral data) and tentative
identification of the phenolic compounds present in the
T. platyphyllos hydroethanolic extract are presented in Table 1.
Eighteen compounds were detected, of which sixteen were fla-
vonoids (three flavan-3-ols and eleven flavonols, one flavanone
and one flavone) and two were phenolic acids. These com-
pounds were previously found in ethanol extracts obtained
from the aerial parts of T. platyphyllos, as described by Jabeur
et al. (2017).3 As in this study, (−)-epicatechin and protocate-
chuic acid were the most abundantly present flavonoid and
phenolic acid respectively. The stability of these extracts was
studied during 5 consecutive days and it was found that on
day 4 the concentration of phenolic compounds began to
decrease (Table 1). Therefore, the feeding water was main-
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tained up to a maximum of 3 days to avoid degradation of
those compounds.
3.2. General findings
During the experimental work no mortality was recorded.
Fig. 1 shows the final body weight and weight gain of animals
in the different groups. There were no differences in the mean
body weight of the animals. The WT linden female group
showed lower weight gain than the WT linden male group (p <
0.05). Fig. 2 shows the mean values of water consumption at
the beginning and at the end of the experimental work.
Female animals from the WT linden group showed lower water
consumption when compared to the matched control (WT
water female group; 4.8 ± 0.03 and 6.8 ± 0.02 g, respectively) (p
< 0.05). The food consumption was similar between the groups
(data not shown). The relative weights of the internal organs
are reported in Table 2. The WT linden-exposed male group and
the HPV linden-exposed male group showed higher right kidney
relative weight than the WT linden exposed female group and
the HPV water exposed male group, respectively (p < 0.05).
3.3. Toxicity evaluation
The serum biochemical parameters are summarized in
Table 3. There were no significant differences between the
groups exposed and non-exposed to linden extract. However,
in exposed female groups the aspartate aminotransferase (AST)
values were higher than in non-exposed female groups, both
in wild-type and transgenic groups. There were no significant
differences between the groups regarding the microhematocrit
values (Table 3). The histological analysis results of skin ear
samples are summarized in Table 4. The HPV groups (linden
exposed and non-exposed) were characterized by moderate to
Fig. 1 Final body weight (g); A. (mean ± standard error) and weight gain (%); B. in all experimental groups. a Statistically different from the HPV
linden male group (p < 0.05); b statistically different from the WT linden female group (p < 0.05).
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marked epidermal hyperplasia, with most animals also exhi-
biting multifocal dysplasia. Although not significant, the HPV
female group not exposed to linden extract showed more epi-
dermal dysplasia than the HPV exposed to linden extract
female group (100 vs. 83.3%, respectively) (p > 0.05) (Fig. 3). A
similar pattern was observed in HPV male mice exposed to
linden extract, which showed less epidermal dysplasia than
animals not exposed (80% vs. 100%, respectively) (p > 0.05).
With regard to carcinoma in situ, it was observed in a small
number of HPV animals not associated with linden adminis-
tration. Regarding internal organs, no significant morphologi-
cal changes were observed across the analysed groups
(Table 5). Several animals presented multifocal inflammatory
aggregates in the liver and kidneys (less than five aggregates),
characterized by the presence of mononuclear or polymorpho-
nuclear cells in both the exposed and non-exposed groups.
Fig. 2 Consumption (g) of water in all experimental groups (mean ± standard error); a statistically different from the WT linden female group (p <
0.05).
Table 2 Relative weight of the internal organs in the experimental groups (mean ± standard error)
Groups Heart Lung Right kidney Left kidney Spleen Liver Thymus
Female HPV linden (n = 6) 0.005 ± 0.0003 0.016 ± 0.0090 0.007 ± 0.0001 0.007 ± 0.0002 0.005 ± 0.0002 0.06 ± 0.0015 0.001 ± 0.0002
HPV water (n = 4) 0.004 ± 0.0001 0.007 ± 0.0003 0.006 ± 0.0003 0.006 ± 0.0003 0.005 ± 0.0004 0.06 ± 0.0009 0.001 ± 0.0002
WT linden (n = 5) 0.004 ± 0.0002 0.007 ± 0.0004 0.005 ± 0.0002 0.017 ± 0.0105 0.004 ± 0.0003 0.06 ± 0.0042 0.0009 ± 0.0002
WT water (n = 4) 0.005 ± 0.0001 0.007 ± 0.0002 0.006 ± 0.0003 0.006 ± 0.0001 0.004 ± 0.0003 0.06 ± 0.0022 0.002 ± 0.0002
Male HPV linden (n = 5) 0.005 ± 0.0005 0.007 ± 0.0003 0.008 ± 0.0004 0.007 ± 0.0017 0.007 ± 0.0007 0.06 ± 0.0027 0.001 ± 0.0003
HPV water (n = 5) 0.005 ± 0.0002 0.006 ± 0.0002 0.007 ± 0.0001a 0.008 ± 0.0002 0.005 ± 0.0007 0.06 ± 0.0019 0.001 ± 0.0004
WT linden (n = 5) 0.005 ± 0.0003 0.006 ± 0.0001 0.007 ± 0.0003b 0.007 ± 0.0003 0.004 ± 0.0006 0.05 ± 0.0020 0.001 ± 0.0001
WT water (n = 7) 0.005 ± 0.0001 0.006 ± 0.0001 0.006 ± 0.0003 0.007 ± 0.0002 0.004 ± 0.0004 0.04 ± 0.0010 0.001 ± 0.0001
a Statistically different from the HPV linden male group (p < 0.05). b Statistically different from the WT linden female group (p < 0.05).
Table 3 Microhematocrit (Ht) and serum parameters (mean ± standard error)
Groups Ht (%) Creatinine (U L−1) Urea (U L−1) ALT (mg dL−1) AST (mg dL−1)
Female HPV linden (n = 6) 44.6 0.3 ± 0.2 82.9 ± 20.8 54.7 ± 11.2 114.4 ± 31.1
HPV water (n = 4) 44.3 0.1 ± 0.0050 133.2 ± 35.4 61.8 ± 7.6 100.1 ± 2.1
WT linden (n = 5) 45.7 0.06 ± 0.02 87.6 ± 16.2 53.3 ± 3.8 117.3 ± 2.0
WT water (n = 4) 44.5 0.4 ± 0.1 65.8 ± 13.9 37.2 ± 1.3 76.7 ± 8.6
Male HPV linden (n = 5) 47.7 0.08 ± 0.03 97.9 ± 11.7 46.4 ± 4.9 79.7 ± 9.1
HPV water (n = 5) 44.3 0.3 ± 0.1 95.8 ± 17.1 56.8 ± 8.4 153.1 ± 29.3
WT linden (n = 5) 42.3 0.7 ± 0.3 65.5 ± 18.8 31.9 ± 6.8 166.3 ± 37.5
WT water (n = 7) 45.1 0.2 ± 0.07 69.3 ± 14.9 41.3 ± 9.9 99.4 ± 11.5
Statistically significant differences were not found.
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Small necrotic areas were rarely observed in HPV animals
exposed to linden (Fig. 3). The spleen was characterized by
extramedullary haematopoiesis and mild to moderate lym-
phoid hyperplasia, with no differences between the groups.
Regarding hepatic stress analysis, the only significant change
was observed in the female for CAT activity, with a decrease in
the HPV female mice compared to the wild-type mice non-
exposed to linden extract (p < 0.05). In the renal oxidative
stress analysis, the only significant change was observed in the
male for CAT activity, with an increase in the wild-type mice
exposed to linden extract compared to the wild-type mice non-
exposed to linden extract (p < 0.05) (Table 6).
Table 4 Histological evaluation of the ear skin
Groups Normal Mild hyperplasia Moderate to marked hyperplasia Dysplasia Carcinoma in situ
Female HPV linden (n = 6) 0 (0%) 0 (0%) 6 (100%) 5 (83.3%) 2 (33.3%)
HPV water (n = 4) 0 (0%) 0 (0%) 4 (100%) 4 (100%) 1 (25%)
WT linden (n = 5) 5 (100%)a 0 (0%) 0 (0%)a 0 (0%)a 0 (0%)
WT water (n = 4) 2 (50%) 2 (50%) 0 (0%)b 0 (0%)b 0 (0%)
Male HPV linden (n = 5) 0 (0%) 0 (0%) 5 (100%) 4 (80%) 0 (0%)
HPV water (n = 5) 0 (0%) 0 (0%) 5 (100%) 5 (100%) 1 (20%)
WT linden (n = 5) 4 (80%)c 1 (20%) 0 (0%)c 0 (0%)c 0 (0%)
WT water (n = 7) 7 (100%)d 0 (0%) 0 (0%)d 0 (0%)d 0 (0%)
a Statistically different from the HPV linden female group (p < 0.05). b Statistically different from the HPV water female group (p < 0.05).
c Statistically different from the HPV linden male group (p < 0.05). d Statistically different from the HPV water male group (p < 0.05).
Fig. 3 Histological analysis of mice samples. a. WT linden female mouse showing normal ear skin; b. ear skin of HPV linden female mouse showing
moderate to marked epidermal hyperplasia (at the top) and dysplasia (at the bottom), associated with dermal inflammatory infiltrate; c. ear skin of
HPV linden female mouse showing carcinoma in situ, associated with marked dermal inflammatory infiltrate; d. liver of HPV linden mouse showing
focal hepatocyte necrosis, associated with neutrophil infiltrate. Hematoxylin and eosin staining.
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A K14HPV16 transgenic mouse model is useful for studying
HPV-induced carcinogenesis. The animals expressed HPV16
oncogenes by cytokeratin-14 human (K14) promoter develop-
ment of viral lesions.15 The lesions are morphologically and
molecularly similar to lesions in HPV-related human disease.29
Recently, several natural products were tested by our team
using the K14HPV16 transgenic mouse model, such as curcu-
min and rutin,30 ptaquiloside from bracken,31 laurel19 and the
red seaweed Phorphyra umbilicalis.32 Numerous natural com-
pounds have been shown to promote health due to their thera-
peutic and chemopreventive properties.33 Yayalaci and collab-
orators used a rat model with ethanol-induced oxidative stress,
to investigate the antioxidant activity of an aqueous extract
obtained from linden flowers.5 Their results indicated that
linden flowers did not protect against alcohol-induced liver
injury and oxidative stress.5 In the present study, we evaluated
the potential in vivo toxicity of the extract of T. platyphyllos
Scop. and its chemopreventive effects against the cutaneous
lesions of this transgenic mouse model. All animals survived
to the experimental protocol and no changes in their mean
body weights were observed. The male wild-type groups
showed a positive weight gain which was not impacted by the
extract. Female animals showed stable weights or slight weight
losses during the experimental period, and the linden extract
was not associated with significant weight differences.
However, the male HPV-transgenic mice exposed to linden
showed a significant lower weight gain compared with
matched untreated animals. These results suggest that the
extract is safe among wild-type mice, but its impact on the
growth of HPV-transgenic mice requires additional investi-
gation. The weight gain differences could not be explained by
different food intake, which was similar among all groups.
Transgenic mice showed higher water intake, as previously
described by our group.30 No association with the extract could




aggregatesMultifocal inflammatory aggregates Focal necrosis
Female HPV linden (n = 6) 0 (0%) 1 (16.7%) 0 (0%)
HPV water (n = 4) 1 (25%) 0 (0%) 0 (0%)
WT linden (n = 5) 2 (40%) 0 (0%) 1 (20%)
WT water (n = 4) 2 (50%) 0 (0%) 0 (0%)
Male HPV linden (n = 5) 2 (20%) 1 (20%) 0 (0%)
HPV water (n = 5) 1 (20%) 0 (0%) 1 (20%)
WT linden (n = 5) 1 (20%) 0 (0%) 0 (0%)
WT water (n = 7) 1 (14.3%) 0 (0%) 2 (28.6%)
Statistically significant differences were not found.
Table 6 Oxidative stress parameters evaluated in the liver and kidneys in the experimental groups (mean ± standard error)
Groups







mg−1 of protein) OSI
LPO (μmol MDA
per mg of protein)
Liver
Female HPV linden (n = 6) 595.8 ± 20.00 171 ± 57.46 199.2 ± 34.67a 138.3 ± 12.88 0.039 ± 0.005 49.65 ± 4.5
HPV water (n = 4) 593.5 ± 37.01 210.3 ± 38.77 186.3 ± 16.77a 137.2 ± 10.18 0.032 ± 0.005 46.08 ± 4.5
WT linden (n = 5) 688.4 ± 28.4 148.2 ± 38.33 305.4 ± 105.9 179.5 ± 21.44 0.025 ± 0.003 49.9 ± 3.1
WT water (n = 4) 709.3 ± 47.46 288.2 ± 39.16 495.2 ± 79.25 141.6 ± 4.522 0.03 ± 0.004 62.94 ± 3.5
Male HPV linden (n = 5) 626.3 ± 34.52 292.2 ± 66.16 203.9 ± 20.67 170.7 ± 3.185 0.28 ± 0.03 61.15 ± 4.2
HPV water (n = 5) 642.8 ± 34.06 194.4 ± 3.578 215 ± 29.03 202.3 ± 15.21 0.31 ± 0.03 61.43 ± 4.4
WT linden (n = 5) 661.8 ± 29.35 311.3 ± 40.57 263.1 ± 34.48 175.6 ± 9.782 0.35 ± 0.02 57.19 ± 4.3
WT water (n = 7) 689.2 ± 29.24 290.6 ± 58.37 282.2 ± 38.37 186.2 ± 15.96 0.37 ± 0.01 53.77 ± 2.6
Kidney
Female HPV linden (n = 6) 598.2 ± 38.76 171.1 ± 24.98 235.2 ± 19.6 55.84 ± 5.646 0.10 ± 0.06 77.22 ± 8.3
HPV water (n = 4) 582.7 ± 69.33 162.1 ± 29.83 173.4 ± 72.8 67.22 ± 9.855 0.11 ± 0.03 76.56 ± 5.2
WT linden (n = 5) 608.8 ± 46.02 166.4 ± 28.03 305.6 ± 20.99 56.14 ± 5.229 0.30 ± 0.11 77.29 ± 2.7
WT water (n = 4) 658 ± 35.69 206.5 ± 38.65 274 ± 46.61 59.62 ± 3.967 0.12 ± 0.01 82.42 ± 8.9
Male HPV linden (n = 5) 461.1 ± 16.09 148.6 ± 54.69 151.9 ± 17.91 26.69 ± 2.281 1.46 ± 0.52 71.18 ± 3.8
HPV water (n = 5) 541 ± 86.03 140.1 ± 27.69 121.5 ± 10.92 22.87 ± 3.496 1.23 ± 0.18 91.59 ± 6.1
WT linden (n = 5) 654 ± 83.7 176.4 ± 18.41 282.1 ± 64.01b 26.24 ± 1.176 1.28 ± 0.23 89.73 ± 5.9
WT water (n = 7) 578.1 ± 62.38 157.3 ± 30.29 185.8 ± 33.71 19.35 ± 2.131 1.13 ± 0.10 80.52 ± 5.0
a Statistically different from the WT water female group (p < 0.05). b Statistically different from the WT water male group (p < 0.05).
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be established, which could indicate low palatability leading to
reduced water consumption and dehydration. As previously
described, HPV-transgenic animals showed retarded growth,
in association with chronic hepatitis and systemic inflam-
mation.30 So, the next analyses were designed to investigate
whether the linden extract could increase liver damage in
HPV16-transgenic mice, especially among male animals,
thereby interfering with animals’ growth. ALT and AST levels,
widely used as serum markers of hepatic damage,34 were not
consistently elevated in association with administration of the
linden extract. Histological analysis demonstrated the presence
of multifocal inflammatory aggregates, especially in the liver,
but no significant changes were observed between the groups,
suggesting that the linden extract was not hepatotoxic in this
model. In line with these findings, the relative weights of the
liver and spleen and the microhematocrit values showed no
significant changes between the groups, supporting the
hypothesis that the linden extract is safe under the present
experimental conditions. High levels of blood urea and creati-
nine are indicators of kidney dysfunction.35 In the present
experiment, the urea and creatinine levels were similar in the
groups, although a single nephritis was observed in linden-
exposed wild-type females. Oxidative stress analysis did not
reveal any statistically significant differences that could be
associated with the oral administration of the linden extract.
These results agree with the previous findings and help defin-
ing a favourable toxicological profile for the linden extract.
This animal model is associated with the development of
cutaneous lesions induced by HPV16 that begins with hyper-
plastic lesions, progressing to dysplastic lesions or even evol-
ving to carcinoma in situ.15,18 The linden extract was associated
with approximately 20% reduction on the incidence of epider-
mal dysplasia, which did not reach statistical significance. In
this animal model, other substances with anti-inflammatory
properties, including flavonoids, were able to reduce the infil-
tration of leukocytes, modulate the expression of cyclooxigen-
ase-2, increase the activity of cytotoxic lymphocytes and signifi-
cantly block the development of HPV16-induced epidermal
lesions at the hyperplastic stage.19,36–39 The present results do
not provide conclusive evidence to support a chemopreventive
role of the linden extract in this model and additional studies
are required to test the efficacy of higher extract doses.
5. Conclusions
The consumption of T. platyphyllos Scop. was well tolerated by
K14HPV16 mice, with no associated significant liver or kidney
damage, supporting the hypothesis that this extract has a
favourable toxicological profile. The results from this study
suggest that the T. platyphyllos Scop. extract has minimal or
null chemopreventive effects against HPV16-induced skin
lesions in this animal model. Future studies should investigate
the functions of the extract’s major bioactive components,
such as protocatechuic acid and (−)-epicatechin. Additional
studies on this subject should employ high dosages, test par-
enteral administration routes or for prolonged administration
periods.
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